Search Results - "Loo, D. Maroeska W. M. te"

Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care by Dittrich, Anne T. M, Smeets, Nori J. L, de Jong, Emma F. M, Kämink, Juliët L, Kroeze, Yvet, Draaisma, Jos M. Th, van Puijenbroek, Eugène P, te Loo, D. Maroeska W. M

“…For drug safety in pediatric patients, knowledge about adverse drug reactions (ADRs) is essential to balance benefits and risks, especially because of the high…”
Get full text

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial by Klaassen, Irene L M, Lauw, Mandy N, van de Wetering, Marianne D, Biemond, Bart J, Middeldorp, Saskia, Abbink, Floor C H, Bierings, Marc, Te Loo, D Maroeska M W, Pieters, Rob, van der Sluis, Inge M, Tissing, Wim J E, Michel Zwaan, C, Heleen van Ommen, C

“…Venous thromboembolism (VTE) is a common and severe complication during treatment of acute lymphoblastic leukemia (ALL). An important cause is the intensive…”
Get full text

GNA11‐mutated Sturge–Weber syndrome has distinct neurological and dermatological features by Dompmartin, Anne, Vleuten, Carine J. M., Dekeuleneer, Valérie, Duprez, Thierry, Revencu, Nicole, Désir, Julie, Loo, D. Maroeska W. M., Flucke, Uta, Eijkelenboom, Astrid, Schultze Kool, Leo, Vikkula, Miikka, Boon, Laurence

“…Background and purpose Sturge–Weber syndrome (SWS) is a neurocutaneous disorder characterized by clinical manifestations involving the brain, eye and skin. SWS…”
Get full text

Health-related quality of life in children with congenital vascular malformations by Bouwman, Frédérique C. M., Verhaak, Chris, de Blaauw, Ivo, Kool, Leo J. Schultze, Loo, D. Maroeska W. M. te, van Rooij, Iris A. L. M., van der Vleuten, Carine J. M., Botden, Sanne M. B. I., Verhoeven, Bas H.

“…A cross-sectional study was performed to evaluate health-related quality of life (HRQOL) in children with congenital vascular malformations (CVM) and to…”
Get full text

Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus by Harbers, Veroniek E. M., Rongen, Gerard A. P. J. M., van der Vleuten, Carine J. M., Verhoeven, Bas H., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Klein, Willemijn M., Schultze Kool, Leo J., Loo, D. Maroeska W. M. te

“…Introduction Patients with congenital vascular malformations often suffer from an impaired quality of life (QoL) because of pain and functional disabilities…”
Get full text

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands by Dittrich, Anne T. M., Draaisma, Jos M. T., van Puijenbroek, Eugène P., Loo, D. Maroeska W. M. te

“…Aims The risk to develop adverse drug reactions (ADRs) is high for paediatric patients. This is, amongst other reasons, due to the inevitable use of off-label…”
Get full text

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities by Hurkmans, Evelien G. E., Klumpers, Marije J., Vermeulen, Sita H., Hagleitner, Melanie M., Flucke, Uta, Schreuder, H. W. Bart, Gelderblom, Hans, Bras, Johannes, Guchelaar, Henk-Jan, Coenen, Marieke J. H., te Loo, D. Maroeska W. M.

“…High-dose methotrexate is a cornerstone agent in the chemotherapeutic treatment of patients with osteosarcoma. However, patients often develop…”
Get full text

Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney Injury by Klumpers, Marije J., Witte, Ward De, Gattuso, Giovanna, Schiavello, Elisabetta, Terenziani, Monica, Massimino, Maura, Gidding, Corrie E. M., Vermeulen, Sita H., Driessen, Chantal M., Van Herpen, Carla M., Van Meerten, Esther, Guchelaar, Henk-Jan, Coenen, Marieke J. H., Te Loo, D. Maroeska W. M.

“…Nephrotoxicity is a common and dose-limiting side effect of platinum compounds, which often manifests as acute kidney injury or hypomagnesemia. This study…”
Get full text

Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus by Harbers, Veroniek E M, Bouwman, Frédérique C M, van Rijnsoever, Ingrid M P, Verhoeven, Bas H, van der Vleuten, Carine J M, Schultze Kool, Leo J, de Laat, Peter C J, van der Horst, Chantal M A M, Kievit, Wietske, Te Loo, D Maroeska W M

“…Vascular malformations are rare congenital anomalies of the vascular system, which can involve the capillaries, veins, arteries, lymphatics, or a combination…”
Get full text

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes by Geelen, Joyce M., van der Velden, Thea J. A. M., te Loo, D. Maroeska W. M., Boerman, Otto C., van den Heuvel, Lambertus P. W. J., Monnens, Leo A. H.

“…Background. After gastrointestinal infection with Shiga-like toxin (Stx) producing Escherichia coli, the toxin is transported from the intestine to the renal…”
Get full text

The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studies by Klumpers, Marije J, Coenen, Marieke JH, Gidding, Corrie EM, Te Loo, D Maroeska WM

“…This systematic review provides an overview of publications concerning pharmacogenetic research in pediatric patients with medulloblastoma and low-grade…”
Get full text

Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity? by te Loo, D Maroeska W M, Hagleitner, Melanie M, Coenen, Marieke J H

Get more information

Age as prognostic factor in patients with osteosarcoma by Hagleitner, Melanie M, Hoogerbrugge, Peter M, van der Graaf, Winette T.A, Flucke, Uta, Schreuder, H.W. Bart, te Loo, D. Maroeska W.M

“…Abstract Age at diagnosis is a well known prognostic factor in many different malignancies; its significance for patients with osteosarcoma is however…”
Get full text

Survival Trends and Long-Term Toxicity in Pediatric Patients with Osteosarcoma by Hagleitner, Melanie M., de Bont, Eveline S. J. M., te Loo, D. Maroeska W. M.

“…Background. This study was conducted to investigate the clinical characteristics and treatment results of osteosarcoma in pediatric patients during the past 30…”
Get full text

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia by Tong, Wing H., Pieters, Rob, Kaspers, Gertjan J.L., te Loo, D. Maroeska W.M., Bierings, Marc B., van den Bos, Cor, Kollen, Wouter J.W., Hop, Wim C.J., Lanvers-Kaminsky, Claudia, Relling, Mary V., Tissing, Wim J.E., van der Sluis, Inge M.

“…This study prospectively analyzed the efficacy of very prolonged courses of pegylated Escherichia coli asparaginase (PEGasparaginase) and Erwinia asparaginase…”
Get full text

Prognostic Significance of Blasts in the Cerebrospinal Fluid Without Pleiocytosis or a Traumatic Lumbar Puncture in Children With Acute Lymphoblastic Leukemia: Experience of the Dutch Childhood Oncology Group by TE LOO, D. Maroeska W. M, KAMPS, Willem A, VAN DER DOES-VAN DEN BERG, Anna, VAN WERING, Elisabeth R, DE GRAAF, Siebold S. N

“…To determine the significance of blasts in the CSF without pleiocytosis and a traumatic lumbar puncture in children with acute lymphoblastic leukemia (ALL). We…”
Get full text

Effective low–dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach–Merritt phenomenon in young infants by Harbers, Veroniek E. M., Salm, Nathalie, Pegge, Sjoert A. H., Vleuten, Carine J. M., Verhoeven, Bas H., Vrancken, Sabine L. A. G., Schultze Kool, Leo J., Fuijkschot, Joris, Loo, D. Maroeska M. W. M.

“…Aims Management of kaposiform haemangioendotheliomas (KHE) with Kasabach–Merritt phenomenon is challenging in young infants who are subjected to developmental…”
Get full text

Contribution of common and rare genetic variants in CEP72 on vincristine‐induced peripheral neuropathy in brain tumour patients by Klumpers, Marije J., Brand, Annouk C. A. M., Hakobjan, Marina, Gattuso, Giovanna, Schiavello, Elisabetta, Terenziani, Monica, Massimino, Maura, Gidding, Corrie E. M., Guchelaar, Henk‐Jan, Loo, D. Maroeska W. M., Coenen, Marieke J. H.

“…Aims Studies implicated a role for a genetic variant in CEP72 in vincristine‐induced peripheral neuropathy. This study aims to evaluate this association in a…”
Get full text

Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events? by van der Vleuten, Carine J.M., Zwerink, Lilly G.J.M., Klappe, Edith M., de Jong, Elke M.G.J., te Loo, D. Maroeska W.M.

Get full text

Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations – A nationwide trial by Harbers, Veroniek E. M., Zwerink, Lilly G. J. M., Rongen, Gerard A., Klein, Willemijn M., Vleuten, Carine J. M., Rijnsoever, Ingrid M. P., Gerdsen‐Drury, Lynda, Flucke, Uta E., Verhoeven, Bas H., Laat, Peter C. J., Horst, Chantal M. A. M., Schultze Kool, Leo J., Loo, D. Maroeska W. M.

“…The clinical presentation of patients with slow‐flow vascular malformations is very heterogeneous. High clinical burden and subsequent reduced health‐related…”
Get full text